Home > Clinical Trials > New Drug for ADHD

New Drug for ADHD

Is your child currently taking medication for ADHD and still have trouble paying attention and/or sitting still?

The following behaviors may signal attention-deficit/hyperactivity disorder (ADHD):

  • Difficulty following instructions or completing tasks
  • "Forgetting” to do things (homework, chores, etc.)
  • Not listening
  • Being easily distracted
  • Being restless or unable to sit still
  • Fidgeting, running around, or seeming “always on the go”
  • Blurting out, interrupting, or talking excessively

If the behaviors above describe your child, and if he or she is 6–17 years old, he or she may be eligible to participate in a clinical research study that involves an investigational drug for ADHD as an addition to your child’s existing stimulant medication.

Your child must have been on a stable dose of ADHD medication for at least four weeks before he or she can participate.

The study will be conducted at the Duke Child and Family Study Center in Durham. Families will be compensated for attending 11 study visits.

For more information, call 919-416-2083.


(REF# 4629)